Our goal is to facilitate the timely publication of high-quality clinical communications. We aim to be the best at what we do and to conduct our activities in an ethical manner that complies with and exceeds current best practice.
The publication of medical information is becoming increasingly regulated, a development that is to be welcomed as it will help to promote an atmosphere of trust and transparency between the pharmaceutical industry, academic researchers and medical journal editors.
A key part of our remit is to constantly monitor the latest guidelines, government edicts, statements from professional bodies, and news items that may have a bearing on pharmaceutical publishing practice. We attend courses to update our knowledge and are members of the International Society for Medical Publication Professionals (ISMPP).
We adhere to the Good Publication Practice (GPP) guidelines, a valuable reference source which is being increasingly accepted by the pharmaceutical industry and medical journal editors alike. The principles encapsulated in the GPP guidelines are echoed in statements issued by numerous other organisations concerned with the standards and ethics of scientific publishing and we look forward to a time when they are universally accepted.
In-depth knowledge of these guidelines, and familiarity with the requirements of individual journals, means that our clients can rely on us to create scientific publications of the highest calibre.